Rockwell Medical Inc. (RMTI)
Symbol Info
Listed Symbol RMTI
Name Rockwell Medical Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $63,388,617
Latest Fiscal EPS $-0.62
Price Info
21 Day Moving Average $2.8607
21 Day EMA $2.685660
50 Day Moving Average $2.6599
50 Day EMA $2.809880
200 Day EMA $3.571480
200 Day Moving Average 3.758430
52 Week High $6.88
52 Week Low $2.19
52 Week Change $-37.406500
Alpha -0.010032
Beta 1.4865
Standard Deviation 0.212076
R2 0.058002
Periods 60
Share Information
10 Day Average Volume 247,742
20 Day Average Volume 267,007
30 Day Average Volume 256,389
50 Day Average Volume 287,629
Outstanding Shares 63,824,584
Float Shares 57,083,900
Percent Float 89.44%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 181
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 2,164,040
Institute Holdings Percent 36.700000
Institute Sold Previous 3 Months 756,484
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 29
Insider Holdings Percent 10.60%
Insider Sold Previous 3 Months -
Insiders Shares Owned 6,740,684
Price Change
7 Day Price Change $-0.0699999
7 Day Percent Change -2.71%
21 Day Price Change $-0.76
21 Day Percent Change -23.24%
30 Day Price Change $-0.48
30 Day Percent Change -16.05%
Month To Date Price Change $-0.25
Month To Date Percent -9.06%
90 Day Price Change $-0.48
90 Day Percent Change -16.05%
Quarter To Date $-0.25
Quarter To Date Percent -9.06%
180 Day Price Change $-2.68
180 Day Percent Change -51.64%
200 Day Price Change $-3.18
200 Day Percent Change -55.89%
Year To Date $0.250000
Year To Date Percent 11.06%
Profile
Description Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products.
Details
Issue Type CS
Market Cap $160,199,706
Sec Type EQS
Auditor Marcum LLP
Total Shares Outstanding 63,824,584
CEO Stuart Paul
Employees 269
Last Audit UE
Classification
CIK 0001041024
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 30142 Wixom Road
Wixom, MI 48393
Website http://www.rockwellmed.com
Facisimile +1 248 960-9119
Telephone +1 248 960-9009
Email invest@rockwellmed.com
Key Ratios
Profitability
EBIT Margin -51.9
EBITDA Margin -49.2
Pre-Tax Profit Margin -39.5
Profit Margin Cont -59.98
Gross Margin 7.70
Profit Margin TOT -59.98
Income Statements
Revenue $47,259,486
Revenue Per Share $0.7405
Revenue 3 Years $0.67
Revenue 5 Years $0.83
Valuation Measures
PE Ratio -
Enterprise Value $146,158,958
Price To Sales 3.389789
Price To Free Cash -7.2
PE High Last 5 Years -
Price To Book 5.4
Price To Cash Flow 76.1
PE Low Last 5 Years -
Price To Tangible Book 5.6
Financial Strength
Total Debt To Equity 0.2
Int Coverage -
Current Ratio 3.3
Leverage Ratio 1.9
Quick Ratio 2.7
Long Term Debt To Capital 0.05
Assets
Receivables Turnover 3.0
Invoice Turnover 13.70
Assets Turnover 0.40
Management Effectiveness
Return Assets -67.65
Return On Equity -143.35
Return On Capital -118.28
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
RMTI
Rockwell M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.